Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.050 | 3.050 | 0.000 |
Stocks | 94.250 | 94.250 | 0.000 |
Preferred | 2.710 | 2.710 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.178 | 18.475 |
Price to Book | 4.301 | 3.781 |
Price to Sales | 3.830 | 5.454 |
Price to Cash Flow | 12.269 | 13.630 |
Dividend Yield | 0.380 | 0.505 |
5 Years Earnings Growth | 8.078 | 21.243 |
Number of long holdings: 69
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 4.92 | 96.95 | +1.42% | |
Regeneron Pharma | US75886F1075 | 4.20 | 683.08 | -0.61% | |
Ultragenyx | US90400D1081 | 3.74 | 43.40 | +2.19% | |
Argen-X | NL0010832176 | 3.13 | 635.00 | +0.54% | |
Vertex | US92532F1003 | 3.12 | 438.40 | -0.71% | |
Rocket Pharma | US77313F1066 | 2.75 | 10.69 | +2.69% | |
Alnylam | US02043Q1076 | 2.73 | 277.16 | +1.16% | |
Neurocrine | US64125C1099 | 2.72 | 153.29 | +1.73% | |
Alltrna, Inc -Series B Preferred Stock | - | 2.71 | - | - | |
Crinetics Pharma | US22663K1079 | 2.62 | 40.26 | +2.23% |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review